ReviewFrontiers in immunology2026
Regulated cell death in sepsis-associated liver injury: molecular mechanisms and therapeutic implications.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanisms and therapeutic strategies of pyroptosis in sepsis‑induced acute lung injury (Review).International journal of molecular medicine · 2026Review
- Lipocalin-2 Restores Mitochondrial and Antioxidant Adaptation in a Strain-Specific Manner During LPS Induced Sepsis.Journal of cellular physiology · 2026Article
- Ferroptosis in vascular injury of critically ill patients: implications of gut microbiota regulation.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis-associated liver injury (SALI) is a critical determinant of sepsis prognosis, characterized by extensive hepatocellular death and dysregulated immune responses. Emerging evidence highlights the pivotal role of regulated cell death (RCD) - including apoptosis, necroptosis, pyroptosis, and ferroptosis - in driving hepatic dysfunction and systemic inflammation. These cell death modalities, once considered distinct, are now recognized as components of an interconnected network that integrates inflammatory, metabolic, and oxidative signals within the liver's unique immunometabolic microenvironment. This review systematically summarizes the molecular mechanisms of major RCD pathways implicated in SALI, and elucidates their crosstalk and convergence through shared mediators such as caspase-8, the NLRP3 inflammasome, lipid peroxidation, and liver-specific metabolic regulators including bile acid signaling. We further discuss key signaling cascades including PI3K/Akt, Nrf2, and NF-κB that orchestrate RCD execution and inflammatory amplification in SALI. By integrating mechanistic insights with emerging translational perspectives, this review highlights RCD as a unifying framework for understanding liver injury and identifying therapeutic entry points to restore hepatic and systemic homeostasis during sepsis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.